TrialActa dermato-venereologica2024

Lebrikizumab Combined with Topical Corticosteroids Improves Patient-reported Outcomes in Japanese Patients with Moderate-to-severe Atopic Dermatitis.

Akio Tanaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.